Why Humanized Liver Mouse Models Are Critical for Drug Metabolism Studies According to a newly published market research report by 24LifeSciences, global humanized liver mice models market was valued at USD 129.4 million in 2026 and is projected to reach USD 225.7 million by 2034, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period. Humanized liver mice models are advanced in vivo research tools created by engrafting functional human hepatocytes into immunodeficient mice. These models are indispensable for studying human-specific liver diseases, drug metabolism, pharmacokinetics, and toxicity profiles because they replicate critical aspects of human liver function, including the expression of cytochrome P450 enzymes and susceptibility to human-tropic pathogens like Hepatitis B and C viruses. Their ability to provide human-relevant data makes them superior to conventional animal models for predicting drug behavior in humans. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9194/humanized-liver-mice-models-market